|
Volumn 16, Issue 5, 2014, Pages 397-399
|
Integrin β3 links therapy resistance and cancer stem cell properties
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA3 INTEGRIN;
GALECTIN 3;
K RAS PROTEIN;
VITRONECTIN RECEPTOR;
B RAF KINASE;
BIM PROTEIN;
BORTEZOMIB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERLOTINIB;
FLT3 LIGAND;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ONCOPROTEIN;
PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE;
PHOSPHOTRANSFERASE;
PROTEIN RALB;
SCATTER FACTOR RECEPTOR;
STEM CELL FACTOR;
TANK BINDING KINASE 1;
UNCLASSIFIED DRUG;
CANCER GROWTH;
CANCER RESISTANCE;
CANCER STEM CELL;
CANCER SURVIVAL;
DISEASE ASSOCIATION;
EPIGENETICS;
GENE MUTATION;
HUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN TRANSPORT;
REVIEW;
SIGNAL TRANSDUCTION;
UBIQUITINATION;
UPREGULATION;
BCR ABL1 GENE;
BIM GENE;
BRAF GENE;
C KIT GENE;
CELL ACTIVITY;
CELL HETEROGENEITY;
DRUG RESISTANCE;
EGFR GENE;
ENZYME ACTIVATION;
EPITHELIAL MESENCHYMAL TRANSITION;
FLT3 GENE;
GENE;
HER2 GENE;
MET GENE;
OXIDATIVE STRESS;
PROTEIN BINDING;
PROTEIN LOCALIZATION;
ANIMALS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INTEGRIN BETA3;
LUNG NEOPLASMS;
NEOPLASTIC STEM CELLS;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS;
RAL GTP-BINDING PROTEINS;
RAS PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 84899847639
PISSN: 14657392
EISSN: 14764679
Source Type: Journal
DOI: 10.1038/ncb2960 Document Type: Review |
Times cited : (20)
|
References (14)
|